Avexis

Discussion in 'Biotech Startups' started by anonymous, Feb 16, 2017 at 10:23 AM.

  1. anonymous

    anonymous Guest

    A company just waiting to take advantage of the helpless. Just an opinion. How much are they going to charge for a treatment?
     

  2. anonymous

    anonymous Guest

    It depends.......how much is your child's life worth?
     
  3. anonymous

    anonymous Guest

    when are they hiring?
     
  4. anonymous

    anonymous Guest

    For people with good exp and take the the time to network and develop relationships always. For people looking for easy info on CP. Never.
     
  5. anonymous

    anonymous Guest

    Thanks for the contribution, tough internet guy.
     
  6. anonymous

    anonymous Guest

    I’m hearing they have a death case in their trial! Isn’t it what we were afraid of?
     
  7. anonymous

    anonymous Guest

    isnt there a new death case in their study?
     
  8. anonymous

    anonymous Guest

    I’m not sure where you got that info. From what I read, as of the beginning of May, all 15 participants were “event free.”
     
  9. anonymous

    anonymous Guest

    Many of the patients are on Spinraza
     
  10. anonymous

    anonymous Guest

    why would anyone use this over spinraza? Doubt insurances will cover dual therapy
     
  11. anonymous

    anonymous Guest

    You hired julie p for program management....hahaaaaaaaa
     
  12. anonymous

    anonymous Guest

    Back stabber with a mood disorder....they will find out soon enough!
     
  13. anonymous

    anonymous Guest

    The North East Manager is useless! Total micro manager, but never ever gets in the field with reps. notorious for that at Genentech. Always answers a question with a question. Doesnt know anything, but good at bullshitting like he does.
     
  14. anonymous

    anonymous Guest

    His team was the bottom of the barrel at Alexion. He’s the best bullsitter you’ll ever meet though
     
  15. anonymous

    anonymous Guest

    At Genentech his team hated him, had no respect for him, and at national meetings never had dinner with his own team. But seems to land jobs which surprises everyone who knows of him. He is great at fooling upper management with rhetorical questions etc.
     
  16. anonymous

    anonymous Guest

    What about the others recently hired here? Didn’t most of them come from the same company?
     
  17. anonymous

    anonymous Guest

    Don’t know about everyone else, but this gig isn’t nearly as fun as I’d thought it would be.

    Too big pharma, no autonomy, no meetings like CNS next week, etc.

    After next year’s payment, I’m bailing and suspect many more will be, too.
     
  18. anonymous

    anonymous Guest

    Did this drug launch yet? If not when
     
  19. anonymous

    anonymous Guest

     
  20. anonymous

    anonymous Guest